|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.75 GBX | 0.00% |
|
-2.27% | -8.51% |
| 12-01 | IXICO plc Announces Scientific Advisory Board Appointments, Effective December 1, 2025 | CI |
| 11-17 | Ixico wins GBP3.7 million deal to support Huntington's Disease trial | AN |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -4.48x | - | 0.11x | 1.11x | -4.11x | -3.05x | - | 13.27M | ||
| 37.75x | 3.89x | 0.62x | 5.5x | 18.58x | 27.1x | 0.92% | 47.37B | ||
| 31.8x | 6.06x | -6.16x | 3.2x | 13.81x | 21.65x | -.--% | 38.46B | ||
| 103.74x | 8.94x | -0.69x | 6.32x | 63.39x | 98.05x | -.--% | 35.73B | ||
| 51.48x | 2.28x | 0.64x | 9.93x | 28.1x | 36.53x | 0.4% | 27.23B | ||
| 37.03x | 36.97x | 2.15x | 5.99x | 27.2x | 28.5x | -.--% | 15.44B | ||
| -14.27x | 9.7x | -0.26x | 5565.23x | -13.5x | -13.29x | -.--% | 15.4B | ||
| 28.78x | 1.52x | -0.89x | 2.13x | 10.9x | 12.12x | -.--% | 14.19B | ||
| -51.58x | 33.61x | 0.68x | 11.12x | 28622.4x | -206.5x | -.--% | 13.64B | ||
| -36.27x | 48.05x | 1.4x | 13.75x | -39.24x | -34.39x | -.--% | 13.23B | ||
| -52.21x | 1358.43x | 1.08x | 14.89x | -122.01x | -89.25x | -.--% | 12.55B | ||
| 23.08x | 2.02x | 0.59x | 1.93x | 8.76x | 13.42x | 1.08% | 12.12B | ||
| 24.46x | 2.72x | 0.06x | 5.06x | 13.7x | 17.09x | 0.44% | 10.19B | ||
| 48.06x | 4.42x | 0.27x | 7.8x | 22.01x | 24x | 0.52% | 9.61B | ||
| 43.95x | 2.58x | 0.02x | 2.75x | 11.41x | 13.89x | -.--% | 9.07B | ||
| -34x | 14.68x | 35.7x | 1398.24x | -36x | -34.79x | - | 8.29B | ||
| 29.65x | 3.43x | -11.49x | 3.64x | 15x | 23.58x | 0.71% | 6.92B | ||
| -18.97x | 6.52x | -0.68x | 21426.23x | -18.44x | -17.85x | -.--% | 6.2B | ||
| Average | 13.78x | 90.93x | 1.29x | 1,582.49x | 1,590.11x | -4.62x | 0.25% | 16.43B | |
| Weighted average by Cap. | 27.86x | 67.61x | 0.22x | 784.23x | 1,330.44x | 10.45x | 0.28% |
- Stock Market
- Equities
- IXI Stock
- Sector IXICO plc
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















